Extracellular Vesicles and Radiomics Predict Durable Response to Immune-Checkpoint Inhibitors in Patients with Non-small Cell Lung Cancer

被引：0

作者：

Perez, D. de Miguel ^{[1
,2
]}

Mamindla, P. ^{[3
]}

Russo, A. ^{[2
,4
]}

Ak, M. ^{[3
,5
]}

Gunasekaran, M. ^{[2
,6
]}

Del Re, M. ^{[1
]}

Buemi, F.

Hirsch, F. R. ^{[1
]}

Cardona, A. F. ^{[7
]}

Arrieta, O. ^{[8
]}

Naing, A. ^{[9
]}

Kaushal, S. ^{[2
,6
]}

Adamo, V. ^{[4
]}

Colen, R. ^{[3
]}

Rolfo, C. ^{[1
,2
]}

机构：

[1] Icahn Sch Med Mt Sinai, New York, NY USA

[2] Univ Maryland, Sch Med, Baltimore, MD USA

[3] Univ Pittsburgh, Med Ctr, Pittsburgh, PA USA

[4] Univ Messina, Messina, Italy

[5] Univ Pittsburgh, Pittsburgh, PA USA

[6] Northwestern Univ, Feinberg Sch Med, Chicago, IL USA

[7] Clin Country, Bogota, Colombia

[8] Inst Nacl Cancerol INCan, Mexico City, DF, Mexico

[9] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA

来源：

关键词：

Non-invasive biomarkers; Immune-checkpoint inhibitors; Liquid biopsy;

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

P1.21-06

引用

页码：S236 / S236

页数：1